Artemisinin Analogue SM934 Ameliorates Murine Experimental Autoimmune Encephalomyelitis through Enhancing the Expansion and Functions of Regulatory T Cell
Li, Xin1; Li, Tian-Tian1; Zhang, Xiao-Hui2; Hou, Li-Fei1; Yang, Xiao-Qian1; Zhu, Feng-Hua1; Tang, Wei1; Zuo, Jian-Ping2
刊名PLOS ONE
2013-08-29
卷号8期号:8
ISSN号1932-6203
DOI10.1371/journal.pone.0074108
文献子类Article
英文摘要Background: Artemisinin analogue SM934 was previously reported to possess immunosuppressive properties. The aim of this study was to determine the effects and the underlying mechanisms of SM934 in murine experimental autoimmune encephalomyelitis (EAE). Methods: Female C57BL/6 mice immunized with MOG(35-55) were treated with or without SM934, then the clinical scores and other relevant parameters were assessed. Th1, Th17 and regulatory T (Treg) cell profiles were determined through ELISA, qRT-PCR, flow cytometry and BrdU incorporation assay. The effects of SM934 on Th1, Th17 and Treg cells differentiation were explored through intracellular staining and flow cytometry examination. Results: In vivo, administration of SM934 significantly inhibited the development of EAE and suppressed the elevation of serum IL-17. Ex vivo, upon antigen-recall stimulation, IL-2, IFN-gamma, IL-17 and IL-6 production were decreased, whereas IL-10 and TGF-beta production were increased from the splenocytes isolated from SM934-treated mice. Consistently, both flow cytometry and qRT-PCR results showed that SM934 treatment significantly increased the Treg, while strongly suppressed the Th17 and Th1, responses in the peripheral. Furthermore, in the spinal lesion, SM934 treatment dramatically decreased the infiltration of CD4(+) T cells, within which the Treg cells percentage was enlarged, whereas the Th17, but not Th1 percentage, was significantly decreased comparing with the vehicle-treated groups. Finally, both BrdU incorporation and in vitro Treg differentiation assays revealed that SM934 treatment could directly promote the expansion of Treg cells in vivo and in vitro. Conclusion: Taken together, this study demonstrated that SM934 treatment could ameliorate the murine EAE disease, which might be mediated by inducing Treg differentiation and expansion.
资助项目National Science Fair Committee (NSFC), China[81072652] ; National Science Fair Committee (NSFC), China[81273524] ; National Science Fair Committee (NSFC), China[81273525] ; National Science & Technology Major Project "New Drug Creation and Manufacturing Program'', China[2012ZX09102-101-006] ; Science 1/4dagger Technology Commission of Shanghai Municipality, China[11431921102]
WOS关键词CENTRAL-NERVOUS-SYSTEM ; MEDIATED SUPPRESSION ; CHEMOKINE RECEPTORS ; IL-17 PRODUCTION ; CUTTING EDGE ; TH17 CELLS ; INFLAMMATION ; DISEASE ; MICE ; INDUCTION
WOS研究方向Science & Technology - Other Topics
语种英语
出版者PUBLIC LIBRARY SCIENCE
WOS记录号WOS:000323734600081
内容类型期刊论文
源URL[http://119.78.100.183/handle/2S10ELR8/277496]  
专题药理学第一研究室
中科院受体结构与功能重点实验室
新药研究国家重点实验室
通讯作者Tang, Wei
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Lab Immunopharmacol, Shanghai 200031, Peoples R China;
2.Shanghai Univ Tradit Chinese Med, Lab Immunol & Virol, Shanghai, Peoples R China
推荐引用方式
GB/T 7714
Li, Xin,Li, Tian-Tian,Zhang, Xiao-Hui,et al. Artemisinin Analogue SM934 Ameliorates Murine Experimental Autoimmune Encephalomyelitis through Enhancing the Expansion and Functions of Regulatory T Cell[J]. PLOS ONE,2013,8(8).
APA Li, Xin.,Li, Tian-Tian.,Zhang, Xiao-Hui.,Hou, Li-Fei.,Yang, Xiao-Qian.,...&Zuo, Jian-Ping.(2013).Artemisinin Analogue SM934 Ameliorates Murine Experimental Autoimmune Encephalomyelitis through Enhancing the Expansion and Functions of Regulatory T Cell.PLOS ONE,8(8).
MLA Li, Xin,et al."Artemisinin Analogue SM934 Ameliorates Murine Experimental Autoimmune Encephalomyelitis through Enhancing the Expansion and Functions of Regulatory T Cell".PLOS ONE 8.8(2013).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace